Solid Biosciences Cash Flow Statement (2017-2024) | SLDB

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Mar2020	Jun2020	Sep2020	Dec2020	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024
Operating Activities
Net Income (Quarter)	-26.70M	-18.99M	-21.25M	-21.36M	-16.90M	-18.70M	-18.03M	-18.65M	-25.32M	-25.09M	-20.40M	-33.03M	-30.35M	-24.89M	-21.26M	-20.61M	-24.31M	-25.31M	-32.94M	-38.05M
Depreciation and Depletion (Quarter)	1.03M	1.33M	0.77M	0.80M	0.73M	0.72M	0.75M	0.76M	0.71M	0.72M	0.44M	0.54M	0.70M	0.70M	0.59M	0.59M
Share-based Compensation (Quarter)	3.10M	3.24M	2.76M	2.52M	2.91M	3.63M	3.42M	3.42M	2.61M	1.81M	1.52M	1.59M	2.12M	1.94M	1.62M	1.94M	1.61M	2.09M	3.00M	3.82M
Gains from Sales and Divestitures (Quarter)				0.41M				0.42M										0.23M	0.24M
Gains from Investment Securities (Quarter)	0.96M	1.39M	1.39M	3.12M	-0.00M	3.00M	0.03M	0.32M	0.17M	0.13M			0.35M	0.92M		-0.49M	0.09M	2.89M	2.94M	-0.32M
Non-cash Items (Quarter)				0.91M												0.86M		1.00M	1.03M
Cash from Operations (Quarter)	-29.27M	-13.07M	-15.56M	1.31M	-21.37M	-17.10M	-18.42M	-20.87M	-27.19M	-15.88M	-20.43M	-34.48M	-28.00M	-27.46M	-17.90M	-20.82M	-25.19M	-21.47M	-23.71M	-29.64M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)	0.02M	-0.00M					-0.53M	-0.58M	-0.37M	-0.15M	0.02M	0.28M	0.21M	0.06M	0.98M	1.15M	0.54M	1.04M	1.21M	0.80M
Depreciation & Amortization (CF) (Quarter)	1.03M	1.33M	0.77M	0.80M	0.73M	0.72M	0.75M	0.76M	0.71M	0.72M	0.44M	0.54M	0.70M	0.70M	0.59M	0.59M	0.33M	1.24M	0.41M	0.49M
Change in Working Capital
Change in Receivables (Quarter)					0.28M	0.01M	0.31M	-0.48M	-0.10M	-0.01M
Change in Account Payables (Quarter)	-4.31M	0.42M	1.29M	-0.83M	-0.09M	-0.23M	0.96M	0.57M	0.07M	0.30M	0.29M	-5.91M	2.75M	-2.71M	-0.93M	0.13M	-0.60M	1.07M	0.92M	0.81M
Change in Accured Expenses (Quarter)	-1.18M	-0.64M	-0.23M	0.89M	-3.92M	-0.61M	-0.30M	2.58M	-0.45M	8.67M	-4.97M	2.57M	-4.91M	-1.32M	0.91M	-1.65M	0.21M	-0.38M	3.31M	1.62M
Other Working Capital Changes (Quarter)	1.21M	-1.57M	-1.09M	1.42M	0.77M	-1.39M	2.26M	7.61M	3.37M	-3.95M	-7.49M		-1.26M	0.44M	-0.31M	0.53M	2.00M	0.04M	0.04M	-0.41M
Investing Activities
Capital Expenditures (Quarter)	0.68M	-0.65M	0.81M	0.06M	0.01M	0.04M	0.57M	-0.52M	0.26M	1.06M	0.84M	-1.63M	0.51M	-0.36M	-0.14M	0.08M	0.02M		0.02M	-0.04M
Cash from Investing Activities (Quarter)	6.42M	0.32M	-0.08M	-0.06M	-0.04M	-48.72M	-72.51M	30.18M	37.74M	-59.59M	14.91M	66.10M	37.26M	-48.23M	-24.64M	45.30M	-38.49M	-5.18M	-10.99M	38.57M
Financing Activities
Other financing activities (Quarter)																	4.83M	0.29M
Cash from Financing Activities (Quarter)					135.15M	-0.24M	0.00M	0.07M	0.02M	0.07M	-0.00M	74.74M				0.51M	107.24M	5.00M	3.26M	6.94M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)
Additional items
Change in Cash (Quarter)	-22.86M	-12.75M	-15.64M	129.95M	113.75M	-66.06M	-90.93M	9.37M	10.57M	-75.40M	-5.52M	106.36M	9.27M	-73.08M	-42.53M	24.98M	43.56M	-21.64M	-31.44M	15.86M
Free Cash Flow (Quarter)	-29.95M	-12.41M	-16.38M	1.25M	-21.38M	-17.14M	-19.00M	-20.36M	-27.45M	-16.93M	-21.27M	-32.85M	-28.50M	-27.10M	-17.76M	-20.90M	-25.21M	-21.47M	-23.72M	-29.61M
Net Cash Flow (Quarter)	-22.86M	-12.75M	-15.64M	1.25M	113.75M	-66.06M	-90.93M	9.37M	10.57M	-75.40M	-5.52M	106.36M	9.27M	-75.70M	-42.53M	24.98M	43.56M	-21.64M	-31.44M	15.86M

Research Tools

Solid Biosciences Cash Flow Statement (2017-2024) | SLDB

Create an account

Sign In

Reset Password